Hims & Hers Health Inc. ($HIMS) Stock Forecast: Down 12.2% Today

What is Hims & Hers Health Inc.?

Hims & Hers Health (NYSE: HIMS) is a digital health company that provides personalized telehealth services and prescription medication delivery.

Why is Hims & Hers Health Inc. going down?

HIMS stock is down 12.2% on Aug 5, 2025 16:46

• The downward movement in HIMS stock today can be attributed to the following factors:
• Weaker than expected Q2 revenue was reported, missing estimates, leading to a significant drop in the stock price.
• A class action lawsuit has been filed against the company and certain senior executives for potential violations of federal securities laws, which may have also contributed to investor concerns and selling pressure.
• Despite beating earnings estimates, the market sentiment towards HIMS was dampened by the revenue miss, causing a negative impact on the stock price.
• The company's near-term challenges, as highlighted by analysts, added to the downward pressure on the stock as investors reevaluated the growth prospects of Hims & Hers Health.

HIMS Price Chart

HIMS Technical Analysis

HIMS News

Hims & Hers Health Posts Weak Q2; Heading Into More Near-Term Challenges, Analysts Say - Hims & Hers Health ( NYSE:HIMS )

Hims & Hers Health reported Q2 revenue of $544.8M, missing consensus of $551.7M. The company reiterated its 2025 revenue and adjusted EBITDA guidance. The market's back, and these 3 income stocks are thriving. See them here→

https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/08/46861750/hims-hers-health-posts-weak-q2-heading-into-more-near-term-challenges-analyst

HIMS CLASS ACTION: Hims & Hers Health, Inc. Investors that Lost Money may have been Affected by Fraud -- Contact BFA Law by August 25 Legal Deadline ( NYSE:HIMS ) - Hims & Hers Health ( NYSE:HIMS )

NEW YORK, Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. HIMS and certain of the Company's senior executives for potential violations of the federal securities laws.

https://www.benzinga.com/pressreleases/25/08/g46854752/hims-class-action-hims-hers-health-inc-investors-that-lost-money-may-have-been-affected-by-fraud-c

Hims & Hers Health Stock Plunges Over 13% In Tuesday Pre-Market: What's Going On? - Hims & Hers Health ( NYSE:HIMS ) , Eli Lilly ( NYSE:LLY )

Hims & Hers Health Inc. HIMS plunged 13.1% in Tuesday pre-market after the digital health company reported second-quarter revenue on Monday that missed Wall Street expectations. ArrivedBuy shares of homes and vacation rentals for as little as $100. Get Started

https://www.benzinga.com/markets/equities/25/08/46852362/hims-hers-health-stock-plunges-over-13-in-tuesday-pre-market-whats-going-on

Hims & Hers Health, Inc. ( HIMS ) Misses Q2 Earnings and Revenue Estimates

Hims & Hers Health (HIMS) delivered earnings and revenue surprises of -5.56% and -1.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2664174/hims-hers-health-inc-hims-misses-q2-earnings-and-revenue-estimates

Hims & Hers Tumbles On Q2 Miss, Highlights Growth Prospects - Hims & Hers Health ( NYSE:HIMS )

Hims & Hers Health reports second-quarter revenue of $544.83 million, missing analyst estimates of $549.83 million. The company reports second-quarter earnings of 17 cents per share, beating estimates of 14 cents per share. The market's back, and these 3 income stocks are thriving. See them here→

https://www.benzinga.com/markets/earnings/25/08/46841094/hims-hers-health-stock-tumbles-on-q2-earnings-as-revenue-comes-up-short-company-sees-exciting-pe

Trending Today

Lido DAO ($LDO) Crypto Forecast: Up 16.0% Today

Ethena ($ENA) Crypto Forecast: Up 11.4% Today

Soybeans ($SOY) Commodity Forecast: Up 1.5% Today

Hims & Hers Health Inc. Price History

24.06.2025 - HIMS Stock was up 9.4%

• HIMS stock rose by 16% recently, amid an ongoing uptrend despite legal issues, including securities fraud allegations and lawsuits.
• Investor sentiment has been buoyed by analysts' optimism and raised price targets, with Truist Securities lifting its target to $48.
• Strong performance is attributed to strategic decisions like the ZAVA acquisition, expansion into the Canadian market, and optimistic earnings per share (EPS) estimates.
• The market appears more focused on the company's growth strategies and potential, overshadowing current legal hurdles and propelling the bullish trend in HIMS stock.

01.07.2025 - HIMS Stock was down 8.3%

• The bearish movement in HIMS stock today could be attributed to the class action lawsuit notification, which might have caused uncertainty and negative sentiment among investors.
• Despite the bullish stance taken by whales in the market, the looming legal issues and uncertainties surrounding the company's stock could have overshadowed the positive investor sentiment.
• The stock's fluctuation could also be influenced by the overall market trend, with weight-loss giants stumbling and potentially impacting the telehealth sector's performance.
• HIMS reaching near all-time highs earlier in the day might have triggered profit-taking by some investors, leading to the bearish movement observed.

01.07.2025 - HIMS Stock was down 8.2%

• Despite positive developments regarding the company's growth and healthcare innovations, HIMS stock displayed bearish movement today.
• Ongoing class action lawsuits against Hims & Hers Health, Inc. could be a contributing factor to the market's bearish reaction, causing uncertainty among investors.
• HIMS had been benefiting from consistent product demand and subscriber growth. However, the presence of legal challenges and uncertainties linked to the lawsuits may have cast a shadow over these favorable aspects, leading to the bearish market trend.
• The stock's performance could be adversely impacted by investor wariness surrounding the legal consequences and imminent deadlines associated with the class action lawsuits.

29.06.2025 - HIMS Stock was up 5.1%

• The bullish movement in HIMS stock could be attributed to positive market sentiment driven by expectations of earnings growth, as Wall Street anticipates a strong performance in the upcoming report.
• Despite facing a lawsuit for securities fraud, investors seem optimistic about the company's future prospects, possibly due to the potential for strategic expansion and earnings growth.
• The announcement of a lawsuit by BFA Law may have initially caused some uncertainty in the market, but the resilience shown by Hims & Hers Health, Inc. in outperforming the broader market indicates that investors are focusing more on the company's long-term potential rather than short-term legal challenges.

30.06.2025 - HIMS Stock was up 10.0%

• HIMS stock experienced a strong bullish movement today, outperforming the broader market with a +1.79% shift.
• The positive market movement could be attributed to the company's resilience and growth potential in the direct-to-consumer health sector.
• The bearish trend in Novo Nordisk (NVO) might have indirectly benefited HIMS, as investors could have shifted focus towards HIMS due to concerns surrounding NVO's obesity drug.
• The ongoing comparison between HIMS and Teladoc Health in terms of earnings growth and strategic expansion could have also contributed to increased investor interest in HIMS, driving the bullish movement.

31.06.2025 - HIMS Stock was up 7.8%

• The class action lawsuit developments may have caused some initial uncertainty among investors. However, strong product demand and subscriber growth leading up to Q2 earnings are believed to have instilled confidence in the company's performance.
• The outperformance of HIMS in comparison to the wider market suggests that investors hold an optimistic outlook on the company's future, despite recent legal issues.
• Weakness in Novo Nordisk and a potential partnership with HIMS that did not materialize have underscored HIMS' relative strength and growth potential within the telehealth industry.
• Despite ongoing legal challenges and negative publicity surrounding the class action lawsuits, market sentiment appears to be more focused on the company's operational strength and potential for growth, driving the bullish movement in HIMS stock.

22.06.2025 - HIMS Stock was up 5.9%

• The acquisition of ZAVA and the planned launch in Canada for affordable obesity care have fueled investor optimism and contributed to the bullish movement.
• Despite the market gains, the stock experienced a temporary drop, possibly due to profit-taking or short-term market fluctuations.
• The securities fraud class action lawsuit against HIMS may have initially caused some uncertainty among investors, but the positive news overshadowed this, leading to the bullish trend.
• The interest of smart money in bearish options on HIMS might have created some volatility, but overall, the company's strategic moves seem to have driven the stock's upward trajectory.

23.06.2025 - HIMS Stock was up 9.5%

• HIMS stock demonstrated a strong bullish movement recently, possibly influenced by favorable developments related to its expansion and acquisition plans.
• The acquisition of ZAVA and the forthcoming launch of affordable obesity care services in Canada are believed to have increased investor confidence in the company's future growth.
• Despite some legal troubles including class action lawsuits, overall market sentiment appears upbeat regarding HIMS' growth prospects, resulting in the positive performance of its stock.
• Investors seem to be placing more emphasis on HIMS' strategic initiatives and growth opportunities over near-term legal challenges, contributing to the upward momentum in the company's stock price.

05.07.2025 - HIMS Stock was down 12.2%

• The downward movement in HIMS stock today can be attributed to the following factors:
• Weaker than expected Q2 revenue was reported, missing estimates, leading to a significant drop in the stock price.
• A class action lawsuit has been filed against the company and certain senior executives for potential violations of federal securities laws, which may have also contributed to investor concerns and selling pressure.
• Despite beating earnings estimates, the market sentiment towards HIMS was dampened by the revenue miss, causing a negative impact on the stock price.
• The company's near-term challenges, as highlighted by analysts, added to the downward pressure on the stock as investors reevaluated the growth prospects of Hims & Hers Health.

05.07.2025 - HIMS Stock was down 7.3%

• The bearish movement in HIMS stock today can be attributed to several factors:
• A class action lawsuit against Hims & Hers Health, Inc. and its senior executives for potential violations of federal securities laws raised concerns among investors, impacting confidence.
• The company's second-quarter revenue fell short of expectations, leading to a significant drop of over 13% in pre-market trading. This revenue miss likely disappointed investors, triggering a sell-off.
• HIMS also failed to meet Q2 earnings and revenue estimates, further weakening investor sentiment and contributing to the stock's decline.
• The accumulation of negative developments, such as the securities law violations lawsuit and the disappointing financial results, likely fueled the bearish movement in the stock today.

18.06.2025 - HIMS Stock was down 5.0%

• Smart money investors have taken a bearish stance on HIMS options, reflecting limited confidence in the stock's short-term performance.
• The pending class action lawsuit against Hims & Hers Health may have contributed to investor uncertainty and selling pressure on the stock.
• Despite recent surges in stock price driven by robust online revenue and subscriber growth, potential challenges ahead might be influencing investor sentiment and leading to the bearish movement.
• The prevailing negative market sentiment towards HIMS, as observed in the decrease in stock price relative to the broader market, indicates investor caution regarding the company's future prospects.

30.06.2025 - HIMS Stock was up 9.0%

• Strong product demand and subscriber growth ahead of Q2 earnings are driving HIMS stock higher.
• The bearish trend in Novo Nordisk (NVO) following a warning related to its weight-loss drug Wegovy could be benefiting HIMS as an alternative.
• Despite class action lawsuits and shareholder alerts, HIMS outperformed the broader market, indicating resilience and investor confidence.
• The upcoming deadline for investors to file a Lead Plaintiff Motion with a law firm may have also contributed to the positive momentum in HIMS stock.